🇺🇸 Saline IV in United States
15 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 15
Most-reported reactions
- Infusion Related Reaction — 3 reports (20%)
- Chest Discomfort — 2 reports (13.33%)
- Dyspnoea — 2 reports (13.33%)
- Therapeutic Product Contamination — 2 reports (13.33%)
- Abdominal Discomfort — 1 report (6.67%)
- Adrenal Insufficiency — 1 report (6.67%)
- Anaphylactoid Reaction — 1 report (6.67%)
- Atrial Fibrillation — 1 report (6.67%)
- Bacteraemia — 1 report (6.67%)
- Blood Urine Present — 1 report (6.67%)
Frequently asked questions
Is Saline IV approved in United States?
Saline IV does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Saline IV in United States?
Rhode Island Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.